Transfusion-associated graft-versus-host disease and its prevention (Q41137670)

27 September 2017

1 reference

title

Transfusion-associated graft-versus-host disease and its prevention (English)

1 reference

27 September 2017

Williamson LM

1

1 reference

PubMed ID

8839400

27 September 2017

Warwick RM

series ordinal

2

1 reference

27 September 2017

1 December 1995

1 reference

27 September 2017

1 reference

27 September 2017

9

1 reference

27 September 2017

4

1 reference

27 September 2017

251-261

1 reference

Erythropoietin for the treatment of porphyria cutanea tarda in a patient on long-term hemodialysis

27 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

Aplastic anemia, histiocytosis and erythrodermia in immunologically deficient children. Probable human runt disease

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

Post-transfusion graft-versus-host disease in immunocompetent patients after cardiac surgery in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

HLA homozygosity and the risk of related-donor transfusion-associated graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

Analysis of risk factors for post-transfusion graft-versus-host disease in Japan. Japanese Red Cross PT-GVHD Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

Graft-versus-host disease from leukocyte transfusions

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

Unusual combined immunodeficiency syndrome exhibiting kappa-IgD paraproteinemia, residual gutimmunity and graft-versus-host reaction after plasma infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

Persistence of donor cells in neonates after fetal and exchange transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

Crucial role of the third and fourth hypervariable regions of HLA-DPB1 allelic sequences in the mixed lymphocyte reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

HLA-DP class II antigens in transfusion-associated graft versus host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

Transfusion-associated graft-versus-host disease: risk due to homozygous HLA haplotypes.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

Transfusion-associated graft-versus-host disease in immunocompetent patients: a self-protective mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

Transfusion-associated graft-versus-host disease: do transfusions from second-degree relatives pose a greater risk than those from first-degree relatives?

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

Brief report: polymorphic microsatellite markers for the diagnosis of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

Diagnosis of transfusion-associated graft-versus-host disease by genetic fingerprinting and polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

Transfusion-associated graft-versus-host disease: report of an occurrence following the administration of irradiated blood

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

Third party mediated graft rejection despite irradiation of blood products

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

X-linked codominant genes control all types of non-major histocompatibility complex-restricted cytotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

The effects of gamma irradiation versus white cell reduction on the mixed lymphocyte reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

A case of transfusion-associated graft-versus-host disease not prevented by white cell-reduction filters

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

Ultraviolet irradiation modulates MHC-alloreactive cytotoxic T-cell precursors involved in the onset of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

Fresh frozen plasma contains viable progenitor cells--should we irradiate?

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

Contamination of fresh-frozen plasma with viable white cells and proliferable stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

Potassium levels in irradiated blood

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

Neonatal mortality following transfusion of red cells with high plasma potassium levels

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

Clinical and laboratory aspects of TA-GVHD with reference to perinatal patients and gamma-irradiated red cell components

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

Evidence based medicine: an approach to clinical problem-solving

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

Posttransfusion graft-versus-host disease in infancy

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

Possible Graft-versus-Host Reaction after Intrauterine Transfusion for Rh Erythroblastosis Fetalis

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

Graft-versus-host disease after intrauterine and exchange transfusions for hemolytic disease of the newborn.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

Intrauterine bone-marrow transplantation at 12 weeks' gestation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

Attempted bone-marrow transplantation in a 17-week fetus

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

Circulating lymphocyte subsets in second- and third-trimester fetuses: comparison with newborns and adults

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

Graft-vs-Host Reaction Following a Single Blood Transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

Graft-versus-host disease following ECMO

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

Fulminant transfusion-associated graft-versus-host disease in a premature infant

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

Maternal isoimmunisation resulting in combined immunodeficiency and fatal graft-versus-host disease in an infant

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

The role of blood from HLA-homozygous donors in fatal transfusion-associated graft-versus-host disease after open-heart surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

Cell-mediated immunity is depressed following cardiopulmonary bypass

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

Post-perfusion syndrome due to Epstein-Barr virus. Report of two cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

Graft versus host disease after transfusions of non-irradiated blood cells in patients having received autologous bone marrow. A report of 4 cases following ablative chemotherapy for solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

Transfusion-induced graft-versus-host disease in patients with malignant lymphoma. A case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

Transfusion‐associated graft‐versus‐host disease in patients with Hodgkin's disease and T cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

Transfusion-associated graft-versus-host disease in fludarabine-treated B-chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

Transfusion-associated graft-versus-host disease in a patient treated with Cladribine (2-chlorodeoxyadenosine): demonstration of exogenous DNA in various tissue extracts by PCR analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2895%2990016-0

7 January 2021

10.1016/S0268-960X(95)90016-0

Identifiers

DOI

1 reference

27 September 2017

1 reference

PubMed ID

8839400